Christopher Perley has been named vice president and general manager of Bristol-Myers Squibb’s Devens biologics manufacturing facility. Mr. Perley will be responsible for continuing the supervision of the project to build the Devens facility and will have overall management responsibility for the site when it becomes operational in 2011.      “With an approved capital expenditure of $750 million, the Devens facility represents the largest capital investment in the history of Bristol-Mye...